Sekisui Aptitude Metrix Covid-19 Test with Reader
Brand: Sekisui Diagnostics, LLC
USD 2146.2 — In stock
How to order
In stock — USD 2146.2.
Prefer to order with a person? +1 855 932 4721 · info@priconmed.com · Contact us.
Variants
- Default Title — USD 2146.2 — In stock — SKU MTRX-C19-B1
Product intelligence — AI-assisted — defer to the manufacturer's IFU
01 — At a glance
Product overview
The Sekisui Aptitude Metrix COVID-19 Test is a molecular diagnostic system designed for the qualitative detection of SARS-CoV-2 nucleic acid. This bundle (SKU MTRX-C19-B1) includes a reusable reader and 50 single-use tests, providing PCR-accurate results through anterior nasal swab or saliva specimens.
- Brand
- Sekisui Diagnostics, LLC
- Packaging
- 50 Tests (2 kits of 25) and 1 Reader
- Test Type
- Molecular SARS-CoV-2 Detection
- Country of Origin
- China
- Regulatory Status
- CLIA-Waived (EUA) and Home Use Authorized
How to think about this product
Procurement staff should distinguish this molecular system from standard rapid antigen tests; while it requires a dedicated electronic reader, it offers PCR-accurate detection that visual-read strips often lack. The bundle format is unique as it pairs the reusable hardware with two 25-count consumable kits, making it suitable for facilities transitioning from centralized lab testing to decentralized or CLIA-waived point-of-care environments. Unlike fully self-contained disposable units, this system relies on a reusable reader, which may influence long-term cost-per-test considerations.
Sources
02 — Clinical applications
Where this product is used
Sekisui Aptitude Metrix Covid-19 Test with Reader is commonly used in:
- Point-of-care molecular COVID-19 screening in clinics
- Non-prescription diagnostic testing for home use
- Qualitative SARS-CoV-2 detection via anterior nasal swabs
- Saliva-based molecular testing for symptomatic individuals
- CLIA-waived respiratory testing in outpatient facilities
03 — People also ask
Frequently asked questions
Q01 What components are included in the MTRX-C19-B1 bundle?
This specific bundle includes one reusable Metrix Reader and two test kits, with each kit containing 25 tests for a total of 50 tests.
Q02 Is this a rapid antigen test or a molecular test?
The Metrix COVID-19 test is a molecular in vitro diagnostic test designed to provide PCR-level accuracy compared to standard antigen tests.
Q03 What specimen types are authorized for use with the Metrix system?
The test is authorized for use with both anterior nasal (nares) swab specimens and saliva specimens.
Q04 Can this test be used in a point-of-care setting?
Yes, it is categorized as CLIA-waived under Emergency Use Authorization (EUA) and is also authorized for non-prescription home use.
Q05 Does the test require a separate device for interpretation?
Yes, the tests must be used in conjunction with the Metrix Reader to analyze and interpret the results.
04 — Wholesale · For verified medical professionals
Need a bulk quote?
Ordering 5+ cases or stocking a facility? Our wholesale team can offer custom pricing, standing orders, and net-30 terms.
- Net-30 terms
- Custom pricing
- 1 business day response